In addition, Muc4 has been shown to impart resistance to the trastuzumab chemotherapeutic agent in breast cancer cells by causing steric interference with the drug (Price-Schiavi et al, 2002; Nagy et al, 2005). The gene discussed is MUC4; the disease is breast carcinoma.